Windtree Therapeutics Inc (WINT): R&D Expense
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$16.28M
Year ended 2024-12-31
$8.54M
Trailing 12 months to 2025-09-30
-2.9%
3-year compound annual growth
+5.1%
5-year compound annual growth
-4.8%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $16.28M | +95.1% | 2025-04-15, From 2024-01-01 |
| 2023-12-31 | $8.34M | -24.8% | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $11.10M | -37.6% | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | $17.79M | +15.7% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $15.37M | +21.2% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $12.69M | +20.1% | 2021-03-29, From 2019-01-01 |
| 2018-12-31 | $10.56M | -39.2% | 2020-04-03, From 2018-01-01 |
| 2017-12-31 | $17.38M | -45.2% | 2019-04-23, From 2017-01-01 |
| 2016-12-31 | $31.70M | +9.8% | 2018-04-17, From 2016-01-01 |
| 2015-12-31 | $28.89M | +8.2% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $26.69M | -3.5% | 2016-03-29, From 2014-01-01 |
| 2013-12-31 | $27.66M | +28.2% | 2015-03-16, From 2013-01-01 |
| 2012-12-31 | $21.57M | +25.2% | 2015-03-16, From 2012-01-01 |
| 2011-12-31 | $17.23M | +0.5% | 2014-03-17, From 2011-01-01 |
| 2010-12-31 | $17.14M | n/a | 2013-03-15, From 2010-01-01 |